What is one FDA label indication for Losartan Potassium?

Losartan Potassium is primarily indicated for the management of hypertension and the reduction of the risk of diabetic nephropathy in patients with type 2 diabetes and hypertension. As an angiotensin II receptor antagonist, it works by blocking the actions of angiotensin II, a substance in the body that can constrict blood vessels and increase blood pressure. By lowering blood pressure, Losartan helps prevent complications associated with uncontrolled hypertension, including heart disease and kidney damage, particularly in diabetic patients.

This specific indication highlights the medication's role in both managing high blood pressure and protecting renal function in at-risk populations, which aligns with the goals of treatment in these patients. The other options describe conditions that are not treated with Losartan, emphasizing its focused use in cardiovascular and renal health rather than in lipid management, respiratory diseases, or allergic conditions like asthma.